Indication

Tocilizumab

3 clinical trials

2 products

1 drug

Clinical trial
Efficacy and Safety of Tocilizumab for Patients With Thyroid-associated Ophthalmopathy
Status: Withdrawn, Estimated PCD: 2023-09-23
Clinical trial
Pilot Study of Tocilizumab Monotherapy for Active Chronic Periaortitis
Status: Completed, Estimated PCD: 2022-12-30